Takeda Pharmaceutical Co., Ltd. (TAK)
15.60
-0.04
(-0.22%)
USD |
NYSE |
Dec 31, 13:02
Takeda Pharmaceutical Market Cap: 49.25B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 264.81B |
| Pfizer Inc. | 141.92B |
| Bristol Myers Squibb Co. | 110.44B |
| Johnson & Johnson | 499.30B |
| Sanofi | 118.66B |
Market Cap Related Metrics
| PE Ratio | 197.91 |
| PS Ratio | 1.679 |
| Price to Book Value | 1.020 |
| Price to Free Cash Flow | 9.022 |
| Price | 15.60 |
| Earnings Yield | 0.51% |
| Operating PE Ratio | 15.18 |
| Normalized PE Ratio | 83.57 |